EUVIMEDEUVIMED entdecken
Crossref

Impact of a dilated main pancreatic duct in the expected remnant pancreas on the incidence of clinically significant remnant pancreatic lesion after resection of noninvasive and microinvasive intraductal papillary mucinous neoplasms

Takuya Mizumoto, Hirochika Toyama, Yoshihide Nanno, Jun Ishida, Yuichiro Uchida, Hideaki Iwama, Masayuki Kojima, Takeshi Takahara, Koichi Suda, Kenji Fukushima, Hidetoshi Gon, Shohei Komatsu und 3 weitere

Pancreatology · 2025

DOI: 10.1016/j.pan.2025.03.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pancreatology, 2025. Verfasst von Takuya Mizumoto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe…. Hauptthemen laut MEDLINE: Pancreatic Ducts, Pancreatectomy, Pancreatic Neoplasms, Pancreatic Intraductal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Partial pancreatectomies for intraductal papillary mucinous neoplasms (IPMN) often leave a dilated main pancreatic duct (MPD). However, its impact on the development of remnant pancreatic lesions is unknown. METHODS: Medical records of consecutive patients who underwent partial pancreatectomy for noninvasive or microinvasive IPMN with dilated MPD on preoperative imaging between April 2007 and March 2023 at two tertiary referral centers in Japan were retrospectively reviewed. A dilated remnant MPD (DRM) was defined as an MPD diameter of the expected remnant pancreas of ≥5 mm. The clinically significant remnant pancreatic lesion (CSRPL) was defined as a remnant pancreatic lesion which requires intervention. RESULTS: A total of 172 patients (106 males and 66 females) were analyzed. Preoperatively, 132 patients (76.7 %) had mixed-type IPMN and 40 (23.1 %) had main duct IPMN. Among them, 16 patients (9.3 %) had CSRPL at 1569 days (median; range, 120-5503 days) after the initial surgery. In the preoperative imaging analysis, 104 patients (60.5 %) had DRM. The univariate analysis revealed that high-grade or micro-invasive pathology (p = 0.013) was significantly associated with CSRPL, whereas DRM was inversely associated with CSRPL (p = 0.021). The multivariate analysis revealed that the trends of DRM (p = 0.002) and high-grade/micro-invasive pathology (p = 0.003) remained significant. CONCLUSIONS: Leaving a dilated MPD did not increase but instead inversely associated with the incidence of CSRPL after IPMN resection. It was suggested that preserving the pancreas, including the dilated MPD, is oncologically safe if the lesion of interest can be resected.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic DuctsPancreatectomyPancreatic NeoplasmsPancreatic Intraductal NeoplasmsCarcinoma, Pancreatic DuctalAdenocarcinoma, MucinousHumansMaleFemaleAgedMiddle AgedRetrospective StudiesAged, 80 and overAdultIncidenceJapanDilatation, PathologicPancreas

Stichwörter der Autor:innen

NeoplasmsPancreatectomyRetrospectiveSurgical oncology

Autor:innen und Institutionen

  • Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan; Department of Surgery, Fujita Health Univers…
  • Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. Electronic address: tymhr@me.com.
  • Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.
  • Department of Surgery, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan.

Zitieren

APA

Mizumoto, T., Toyama, H., Nanno, Y., Ishida, J., Uchida, Y., Iwama, H., Kojima, M., Takahara, T., Suda, K., Fukushima, K., Gon, H., Komatsu, S., Yanagimoto, H., Kido, M., & Fukumoto, T. (2025). Impact of a dilated main pancreatic duct in the expected remnant pancreas on the incidence of clinically significant remnant pancreatic lesion after resection of noninvasive and microinvasive intraductal papillary mucinous neoplasms. Pancreatology. https://doi.org/10.1016/j.pan.2025.03.012

Vancouver

Mizumoto T, Toyama H, Nanno Y, Ishida J, Uchida Y, Iwama H, et al. Impact of a dilated main pancreatic duct in the expected remnant pancreas on the incidence of clinically significant remnant pancreatic lesion after resection of noninvasive and microinvasive intraductal papillary mucinous neoplasms. Pancreatology. 2025. doi:10.1016/j.pan.2025.03.012

BibTeX
@article{Mizumoto2025,
  author = {Mizumoto, Takuya and Toyama, Hirochika and Nanno, Yoshihide and Ishida, Jun and Uchida, Yuichiro and Iwama, Hideaki and Kojima, Masayuki and Takahara, Takeshi and Suda, Koichi and Fukushima, Kenji and Gon, Hidetoshi and Komatsu, Shohei and Yanagimoto, Hiroaki and Kido, Masahiro and Fukumoto, Takumi},
  title = {Impact of a dilated main pancreatic duct in the expected remnant pancreas on the incidence of clinically significant remnant pancreatic lesion after resection of noninvasive and microinvasive intraductal papillary mucinous neoplasms},
  journal = {Pancreatology},
  year = {2025},
  doi = {10.1016/j.pan.2025.03.012}
}
Kostenlos starten →